NCT05138744

Brief Summary

Evaluate the effectiveness of a brief, virtual reality intervention for depressed mood

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable depression

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 1, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

December 5, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2022

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2022

Completed
Last Updated

December 1, 2021

Status Verified

November 1, 2021

Enrollment Period

2 months

First QC Date

July 26, 2021

Last Update Submit

November 30, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Behavioral activation

    In a scale from 0 (not at all) to 6 (completely), "to what extent were you satisfied with what you did today?"

    Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline vs posttreatment)

Secondary Outcomes (5)

  • Change in Mood

    Change through study completion, an average of 31 days. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  • Change in Depression

    Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  • Change in Positive affect

    Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  • Change in Negative affect

    Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

  • Change in Activity level

    Change through study completion, an average of 31 days.. The outcome will be evaluated daily (at 9pm) during 31 days. Changes will be investigated from baseline to posttreatment using all corresponding time points (baseline to posttreatment)

Study Arms (1)

Virtual reality treatment

EXPERIMENTAL

Use of google maps with virtual reality to virtually situate the participants into scenarios that are motivating for them (i.e., the beach, a mountain, a park, etc.) at their choice.

Other: Behavioral activation using virtual reality

Interventions

The investigators will encourage behavioral activation (increase in the number and time of conducted activities) situating the person in motivating situations using virtual reality

Virtual reality treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient Health Questionnaire - 9 (measure of depression) over 9
  • Positive and Negative Affect Schedule (measure of positive and negative affect): positive affect score below 24
  • Age over 18 years
  • Signs informed consent

You may not qualify if:

  • Completes more than 20% of evaluations retrospectively (not the day they are assigned)
  • Has a severe mental health disorder as evaluated with the MINI International Neuropsychiatric Interview
  • Does not sign the informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Desirée Colombo, PhD

CONTACT

Carlos Suso, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single case design (multiple baselines)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2021

First Posted

December 1, 2021

Study Start

December 5, 2021

Primary Completion

January 22, 2022

Study Completion

February 20, 2022

Last Updated

December 1, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Data will be anonymized and will only be shared upon reasonable request without identifying information